CIMA Labs Completes Manufacturing Facility and Appoints New Executive
CIMA Labs Inc., a drug delivery company founded in 1987, has completed the manufacturing facility for its OraSolv(R) technology-based products. The 75,000 square foot facility, located in Eden Prairie, Minnesota, has an initial production capacity of 400 million tablets per year and can be expanded to six production lines, achieving a maximum capacity of 2.4 billion tablets per year. CIMA has also appointed Jack Khattar as Vice President of Business Development, reporting to Senior Vice President of Business Development. Khattar joins CIMA from Merck & Co., Inc., where he managed the switch from prescription to over-the-counter status of several drugs, including Pepcid(R) AC.
Key Takeaways:
- CIMA Labs has completed a 75,000 square foot manufacturing facility for its OraSolv(R) technology-based products, with an initial capacity of 400 million tablets per year.
- The facility is located in Eden Prairie, Minnesota, and serves as CIMA's corporate headquarters.
- CIMA has appointed Jack Khattar as Vice President of Business Development, with a background in business development and pharmaceutical product marketing.
- Khattar joins CIMA from Merck & Co., Inc., where he managed the switch from prescription to over-the-counter status of several drugs, including Pepcid(R) AC.
- CIMA has a License and Supply Agreement with Merck for the development of Pepcid(R) AC using CIMA's AutoLution(R) technology to be marketed internationally.
- CIMA is a publicly traded company, listed on the Nasdaq since July 1994.
- The company has partnerships with Pfizer Inc., Glaxo Group Limited, and Sterling Winthrop, Inc./SmithKline Beecham, plc/Bayer A.G. for various OraSolv(R) products.
Statistics:
- Initial production capacity: 400 million tablets per year
- Maximum production capacity: 2.4 billion tablets per year
- Facility size: 75,000 square feet
- Employment of Jack Khattar: since 1981
- Length of experience at Merck & Co., Inc.: 14 years
- Number of products managed by Khattar at Merck & Co., Inc.: several
Sources:
- BUSINESS WIRE, February 14, 1995
- CIMA Labs Inc.
- Merck & Co., Inc.
- The Wharton School of the University of Pennsylvania